Evidence map›Paper›PMID 30666745›Full record

ArticleProtein science : a publication of the Protein Society2019

Application of the NZ-1 Fab as a crystallization chaperone for PA tag-inserted target proteins.

Risako Tamura, Rika Oi, Satoko Akashi, Mika K Kaneko, Yukinari Kato, Terukazu Nogi

Erratum issuedAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Preparing for successful protein crystallization experiments.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  2. Article
  3. Article
  4. A Novel Anti-CD44 Variant 3 Monoclonal Antibody CInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. A Novel Anti-CD44 Variant 9 Monoclonal Antibody CCurrent issues in molecular biology · 2023
    Article
  7. Article
  8. Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody CCurrent issues in molecular biology · 2023
    Article
  9. Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody CInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Risako TamuraGraduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Rika OiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Satoko AkashiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Mika K KanekoTohoku University Graduate School of Medicine, Tohoku, Japan.
Yukinari KatoTohoku University Graduate School of Medicine, Tohoku, Japan.
Terukazu NogiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.ORCID 0000-0001-8663-3519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An antibody fragment that recognizes the tertiary structure of a target protein with high affinity can be utilized as a crystallization chaperone. Difficulties in establishing conformation-specific antibodies, however, limit the applicability of antibody fragment-assisted crystallization. Here, we attempted to establish an alternative method to promote the crystallization of target proteins using an already established anti-tag antibody. The monoclonal antibody NZ-1 recognizes the PA tag with an extremely high affinity. It was also established that the PA tag is accommodated in the antigen-binding pocket in a bent conformation, compatible with an insertion into loop regions on the target. We, therefore, explored the application of NZ-1 Fab as a crystallization chaperone that complexes with a target protein displaying a PA tag. Specifically, we inserted the PA tag into the β-hairpins of the PDZ tandem fragment of a bacterial Site-2 protease. We crystallized the PA-inserted PDZ tandem mutants with the NZ-1 Fab and solved the co-crystal structure to analyze their interaction modes. Although the initial insertion designs produced only moderate-resolution structures, eliminating the solvent-accessible space between the NZ-1 Fab and target PDZ tandem improved the diffraction qualities remarkably. Our results demonstrate that the NZ-1-PA system efficiently promotes crystallization of the target protein. The present work also suggests that β-hairpins are suitable sites for the PA insertion because the PA tag contains a Pro-Gly sequence with a propensity for a β-turn conformation.

Indexed as

Antibodies, MonoclonalAquifexBacteriaBacterial ProteinsCrystallizationCrystallography, X-RayImmunoglobulin Fab FragmentsModels, MolecularPDZ DomainsPeptide HydrolasesProtein ConformationAntibodies, MonoclonalBacterial ProteinsImmunoglobulin Fab FragmentsPeptide Hydrolasesantigen-binding fragmentcrystallization chaperoneepitope tag insertionmonoclonal antibodyprotein crystallography

Identifiers

PMID30666745
PMCPMC6424065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.